Article Details

Ofatumumab treatment for concomitant multiple sclerosis and idiopathic thrombocytopenic purpura

Retrieved on: 2025-02-20 16:51:32

Tags for this article:

Click the tags to see associated articles and topics

Ofatumumab treatment for concomitant multiple sclerosis and idiopathic thrombocytopenic purpura. View article details on hiswai:

Excerpt

Considering the pharmacological similarities of ofatumumab to rituximab (a second-line treatment for ITP), anti-CD20 monoclonal antibodies such as ...

Article found on: www.frontiersin.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo